The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and
needle biopsies of muscle will quantify changes in any of seven different glucose transport
proteins in muscle.